![Citeline Podcasts artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/0f/4f/ef/0f4fef8f-28fc-8de1-8d89-184cfda23e39/mza_5528053617673757912.jpg/100x100bb.jpg)
HBW Insight Podcast: EU Pre/Probiotics, UK CBD Deadline, GSK Advances Sustainability
Citeline Podcasts
English - March 29, 2021 09:30 - 16 minutes - 12 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Scrip’s Five Must-Know Things – 29 March 2021
Next Episode: OTC Marketing Awards 2021 Entry Podcast
HBW Insight editors discuss the latest European consumer healthcare industry news. This week, Tom Gallen and David Ridley examine how a growing number of EU member states are allowing prebiotic and probiotic on food supplement labels, despite EFSA regulations; a last minute revision of the UK's CBD regulations, which allow products linked to a novel food application - not necessarily validated - to remain on the market from the end of this month, as well as a group of companies that have all received a pre-validation from the FSA thanks to a consortium-based approach; and finally how GSK is exploring sustainable paper bottles for three of its biggest consumer health brands to advance its ambitious sustainability strategy.